Fabrice Egros, Director at Syndax Pharmaceuticals Inc (SNDX), sold 28,030 shares at $18.03 ($505K) on 2021-11-18, disclosed to the SEC on 2021-11-19.
Open-market sale of $505k SNDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.03 | 30 | $541 | 0.1% |
| 2 | $18.03 | 14,000 | $252K | 49.9% |
| 3 | $18.03 | 14,000 | $252K | 49.9% |
| Total | $18.03 avg | 28,030 | $505K | 100% |
| Filing → |
| SNDX | SELL | 2021-03-03 | $496K | — | Filing → |